Novel medications to treat addictive disorders - Wikidata - awgldk - TriplyDB

Novel medications to treat addictive disorders

Novel medications to treat addictive disorders

http://www.wikidata.org/entity/Q37029633

about

Decreased reinforcing effects of cocaine following 2 weeks of continuous D-amphetamine treatment in rats.The methamphetamine problem in the United States.Pharmacological treatment of cannabis dependence.Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy.Buspirone reduces sexual risk-taking intent but not cocaine self-administration.Glutamatergic medications for the treatment of drug and behavioral addictions.Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and Without Cocaine Dependence.Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.Epigenetics: a link between addiction and social environment.Rapid access to morphinones: removal of 4, 5-ether bridge with Pd-catalyzed triflate reduction.[Cue exposure treatment and coping skills training as adjuvant therapies in the management of craving in a crack cocaine addict].

P2860

Q30479418-B3CDFF37-E171-42FE-9272-A155074985E9 Q34092520-DACA8462-4481-4E9A-AFE4-7538FF4C7CBE Q35210350-A2411A99-3341-4988-A876-3B53D0988798 Q36936280-37C7ED00-B773-40F0-B4B5-3C4264D04C45 Q36976585-5A9B9F98-2D98-4911-BFFA-CB5ADE377133 Q37871133-66F3570F-9782-406A-B2B1-BA484F14927C Q38600702-C128AE57-7DE2-45AC-90CC-BA6B5BF6DD5C Q38857113-513F4C21-BAD3-4900-AD43-26B87872FE95 Q39159282-25ABEC5E-D97E-405C-A212-96327F6F01E0 Q40632677-57727F98-B5CA-4B54-8516-C799E70C34C3 Q52306974-591BC7D4-F96F-4F5B-AE16-C3A86829AB4E

P2860

Novel medications to treat addictive disorders

http://www.wikidata.org/entity/Q37029633

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel medications to treat addictive disorders

@en

Novel medications to treat addictive disorders.

@nl

type

label

Novel medications to treat addictive disorders

@en

Novel medications to treat addictive disorders.

@nl

prefLabel

Novel medications to treat addictive disorders

@en

Novel medications to treat addictive disorders.

@nl

P1433

Q37029633-368553AB-EE8C-4086-99FA-7373F6825527

P1476

Q37029633-0A628A9B-32A4-421F-ADCD-0A35F324FE37

P2093

Q37029633-70F41171-88CC-4B22-9474-73EC3CC4162C

Q37029633-F78FBBE5-190A-4910-9511-6D8CFF71E724

P2860

Q37029633-01166EAD-458E-43A0-B1D4-02F278DF8714

Q37029633-042B98CD-0AFF-4AC6-9B76-ED5A3EBBA372

Q37029633-0AEFE103-0964-4351-AD08-203711644342

Q37029633-0E760C13-B010-4232-A127-63CB148B04C4

Q37029633-12094D7A-416F-43D1-B4AE-09C1B571D3CD

Q37029633-1694F661-F80B-4829-8D56-7D6FDCC9BC89

Q37029633-21A97AB3-62C3-4B93-B3FD-80294568917F

Q37029633-220FAD4F-A34C-4FCE-9C77-7FA9899DB0D9

Q37029633-2FC00F92-386B-415F-9E5D-CFDF9247232C

Q37029633-38B4FFEB-C467-4455-9343-91026388BCBB

P2888

Q37029633-D33A6EFF-828F-496A-A847-67DDC758F725

P304

Q37029633-32DA8A44-A72B-462D-826D-60B6BCD7C737

P31

Q37029633-189d0d72-23e0-4a79-a7eb-f133f0d9964a

Q37029633-2473ED77-4D58-4294-A170-C3CCF8E1093C

P356

Q37029633-66754CBF-EF96-48D9-9C22-17D386D8EBEA

P407

Q37029633-69A3079D-1110-4099-848A-0330851F26E9

P433

Q37029633-A11122E7-BA23-4BEC-81E8-C3C4402E7BD8

P478

Q37029633-97B8D0DB-F5ED-4313-84A6-4789B56DE383

P577

Q37029633-94DBB1A8-A368-4F55-8BB6-0ED99793B2F0

P5875

Q37029633-BC949FE9-7451-42F4-B27E-923C3E635F15

P698

Q37029633-56CC6D2A-86A3-4F8B-AE02-C490965C993F

P932

Q37029633-D7023B2A-EC6A-40C2-BCE9-B73A4645FD7F

P356

S11920-008-0063-9

P1433

Current Psychiatry Reports

P1476

Novel medications to treat addictive disorders

@en

P2093

Frank Vocci

http://www.w3.org/2001/XMLSchema#string

Iván D Montoya

http://www.w3.org/2001/XMLSchema#string

P2860

Kappa opioids as potential treatments for stimulant dependence

New treatments for cocaine dependence: a focused review

Vaccine pharmacotherapy for the treatment of cocaine dependence

Lobeline effects on tonic and methamphetamine-induced dopamine release

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.

Lobeline inhibits the neurochemical and behavioral effects of amphetamine.

The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction.

Management of methamphetamine abuse and dependence.

P2888

s11920-008-0063-9

P304

392-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11920-008-0063-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23269026

http://www.w3.org/2001/XMLSchema#string

P698

18803912

http://www.w3.org/2001/XMLSchema#string

P932

2610431

http://www.w3.org/2001/XMLSchema#string